Authors:
Schleman, KA
Lindenfeld, JA
Lowes, BD
Bristow, MR
Ferguson, D
Wolfel, EE
Abraham, WT
Zisman, LS
Citation: Ka. Schleman et al., Predicting response to carvedilol for the treatment of heart failure: A multivariate retrospective analysis, J CARD FAIL, 7(1), 2001, pp. 4-12
Authors:
Dash, R
Kadambi, VJ
Schmidt, AG
Tepe, NM
Biniakiewicz, D
Gerst, MJ
Canning, AM
Abraham, WT
Hoit, BD
Liggett, SB
Lorenz, JN
Dorn, GW
Kranias, EG
Citation: R. Dash et al., Interactions between phospholamban and beta-adrenergic drive may lead to cardiomyopathy and early mortality, CIRCULATION, 103(6), 2001, pp. 889-896
Citation: Wt. Abraham, Anti-adrenergic therapy in hypertensive patients with concomitant disease, PREVENTION OF DISEASE PROGRESSION THROUGHOUT THE CARDIOVASCULAR CONTINUUM, 2001, pp. 16-28
Citation: Dp. Suresh et al., New developments in heart failure: Role of endothelin and the use of endothelin receptor antagonists, J CARD FAIL, 6(4), 2000, pp. 359-368
Citation: Wt. Abraham, Rationale and design of a randomized clinical trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with advanced heart failure: The Multicenter InSync Randomized Clinical Evaluation (MIRACLE), J CARD FAIL, 6(4), 2000, pp. 369-380
Authors:
Franciosa, JA
Abraham, WT
Fowler, M
Gilbert, EM
Greenberg, B
Massie, BM
Chen, T
Lukas, MA
Nelson, JJ
Citation: Ja. Franciosa et al., Rationale, design, and methods for a Coreg (Carvedilol) heart failure registry (COHERE), J CARD FAIL, 6(3), 2000, pp. 264-271
Authors:
Colucci, WS
Elkayam, U
Horton, DP
Abraham, WT
Bourge, RC
Johnson, AD
Wagoner, LE
Givertz, MM
Liang, CS
Neibaur, M
Haught, WH
Citation: Ws. Colucci et al., Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure., N ENG J MED, 343(4), 2000, pp. 246-253
Authors:
Wagoner, LE
Craft, LL
Singh, B
Suresh, DP
Zengel, PW
McGuire, N
Abraham, WT
Chenier, TC
Dorn, GW
Liggett, SB
Citation: Le. Wagoner et al., Polymorphisms of the beta(2)-adrenergic receptor determine exercise capacity in patients with heart failure, CIRCUL RES, 86(8), 2000, pp. 834-840
Authors:
Takeishi, Y
Jalili, T
Hoit, BD
Kirkpatrick, DL
Wagoner, LE
Abraham, WT
Walsh, RA
Citation: Y. Takeishi et al., Alterations in Ca2+ cycling proteins and Gag signaling after left ventricular assist device support in failing human hearts, CARDIO RES, 45(4), 2000, pp. 883-888
Authors:
Havranek, EP
McGovern, KM
Weinberger, J
Brocato, A
Lowes, BD
Abraham, WT
Citation: Ep. Havranek et al., Patient preferences for heart failure treatment: Utilities are valid measures of health-related quality of life in heart failure, J CARD FAIL, 5(2), 1999, pp. 85-91
Citation: Py. Martin et al., Selective V2-receptor vasopressin antagonism decreases urinary aquaporin-2excretion in patients with chronic heart failure, J AM S NEPH, 10(10), 1999, pp. 2165-2170
Citation: Wt. Abraham et B. Singh, Ischemic and nonischemic heart failure do not require different treatment strategies, J CARDIO PH, 33, 1999, pp. S1-S7
Authors:
Chapman, AB
Abraham, WT
Zamudio, S
Coffin, C
Merouani, A
Young, D
Johnson, A
Osorio, F
Goldberg, C
Moore, LG
Dahms, T
Schrier, RW
Citation: Ab. Chapman et al., Temporal relationships between hormonal and hemodynamic changes in early human pregnancy (vol 54, pg 2056, 1998), KIDNEY INT, 55(3), 1999, pp. 1185-1185
Authors:
Lowes, BD
Gill, EA
Abraham, WT
Larrain, JR
Robertson, AD
Bristow, MR
Gilbert, EM
Citation: Bd. Lowes et al., Effects of carvedilol on left ventricular mass, chamber geometry, and mitral regurgitation in chronic heart failure, AM J CARD, 83(8), 1999, pp. 1201-1205